Prophylaxis of Neuropathic Pain by mémantine
NCT01536314
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Neuropathic Pain
Interventions
DRUG:
Memantine EBIXA®
DRUG:
Placebo : lactose
Sponsor
University Hospital, Clermont-Ferrand